BioAge Labs Inc. logo

BioAge Labs Inc.

BIOA | NASDAQ
Chart Builder DCF Calculator
$8.46
+$0.37 (+4.57%)
At close: Sep 22, 2026, 4:00 PM ET
$8.49
+$0.03 (+0.35%)
After-hours: Sep 22, 2026, 7:30 PM ET

Market Data

Market Cap
$304.59M
Enterprise Value
$-11.32M
Beta
0.94
Average Volume
723.55K
Shares Outstanding (Diluted)
44.84M
Shares Change YoY
25.07%
Institutional Ownership
80.72%
Exchange
NASDAQ
ISIN
US09077V1008

Price Performance

Price Change 1M
-15.4%
Price Change 3M
-63.8%
Price Change 6M
-50.7%
Price Change YTD
-36.9%
Price Change 1Y
58.3%
Price Change 3Y
-61.5%
Price Change 5Y
-61.5%
1M CAGR (ann.)
-31.0%
1Y CAGR (ann.)
55.0%
5Y CAGR (ann.)
N/A
All-Time CAGR
-33.7%

Valuation

PE Ratio
-3.40
Forward PE
N/A
PEG Ratio
0.46
Forward PEG
0.32
PS Ratio
29.41
Forward PS
19.40
PB Ratio
0.81
P/FCF Ratio
-2.72
P/Adj. FCF Ratio
-2.33
P/OCF Ratio
-4.15
EV/Sales
-1.09
EV/EBIT
0.11
EV/EBITDA
0.11
EV/FCF
0.10
Earnings Yield
-29.4%
FCF Yield
-36.8%
Adj. FCF Yield
-42.8%

Financial Health

Net Cash
$318.03M
Total Debt
$2.84M
Cash & Short-Term Investments
$318.75M
Total Assets
$396.93M
Current Ratio
17.19
Quick Ratio
17.19
Debt / Equity Ratio
0.01
Debt / EBITDA
-0.03
Debt / FCF
-0.03
OCF / Debt
-39.38
Interest Coverage
-378.19
Altman Z-Score
7.08
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
99.4%
Operating Profit Margin
-1026.3%
EBITDA Margin
-907.1%
Net Profit Margin
-912.3%
FCF Margin
-1083.2%
Adj. FCF Margin
-1259.8%
SBC / Revenue
135.6%
SBC Impact (per share)
-16.3%

Returns

Return on Assets
-23.8%
Return on Equity
-29.0%
Return on Invested Capital
-28.1%
Return on Capital Employed
-28.1%
Return on Tangible Assets
-23.8%

Historical Growth (CAGR)

Revenue CAGR 3Y
109.3%
Revenue CAGR 5Y
N/A
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
-13.1%
EPS CAGR 5Y
N/A
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-44.2%
FCF CAGR 5Y
N/A
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
6
EPS Growth Next 3Y
-7.1%
Revenue Growth Next 3Y
-25.1%
Earnings Date
Nov 4, 2026
EPS Estimate (next Q)
-$0.66
EPS Growth Est (next Q)
17.9%
Revenue Est (next Q)
$1.53M
Revenue Growth Est (next Q)
-25.5%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$34
Price Target Upside
320.3%

Cash Flow

Operating Cash Flow
$-111.65M
Free Cash Flow
$-112.16M
Adj. Free Cash Flow
$-130.46M
FCF Per Share
-$1.96
OCF Per Share
-$1.95
OCF/S Ratio
-846.0%

Income Statement

Revenue
$10.36M
Gross Profit
$10.29M
Operating Income
$-106.27M
EBITDA
$-100.48M
Net Income
$-94.46M
EPS (Diluted)
-$2.38
Revenue / Employee
$169.75K
Profit / Employee
$-1.55M
Employees
61

© 2026 bestshares.com. All rights reserved.